Adicet Bio, Inc. (ACET) vs Elicio Therapeutics, Inc. (ELTX)

Adicet Bio, Inc. and Elicio Therapeutics, Inc. are both Biotechnology companies. Adicet Bio, Inc. and Elicio Therapeutics, Inc. are of similar size ($48.2M and $48.1M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against 224.6%. Across the 13 metrics below, Elicio Therapeutics, Inc. leads on 7 and Adicet Bio, Inc. on 6.

Valuation

Metric ACET ELTX Biotechnology median
P/E n/m n/m 8.50
P/S 1.27 1.04 9.71
P/B 0.41 3.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.67 n/m 0.64
EV/Sales (1.77) 0.59 9.21
Earnings yield (250.55%) (139.10%) (33.15%)
Free cash flow yield (173.02%) (125.90%) (25.50%)

Profitability

Metric ACET ELTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (78.08%) (774.56%) (56.36%)
Return on assets (63.62%) (124.36%) (48.04%)
Return on invested capital (2,518.16%) 0.00% 0.00%

Growth

Metric ACET ELTX Biotechnology median
Revenue growth (TTM) 224.62% 921.02% 6.02%
EPS growth (last fiscal year) 20.35% 39.29% 30.26%
Revenue growth, 5-year CAGR 6.90% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACET ELTX Biotechnology median
Debt to equity 0.01 1.20 0.00
Current ratio 6.71 2.77 4.72
Net debt to EBITDA 1.32 0.25 0.96

Dividend

Metric ACET ELTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACET ELTX Biotechnology median
Market cap 48.12m 48.22m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack